Keine Internetverbindung – die gespeicherte Version der Seite wird angezeigt.

Merck KGaA ADR

USUSD
← Zum Screener

Merck KGaA ADR (LSE:0QAH) — Biotechnology: Pharmaceutical Preparations. Anzahl der Börsen, an denen die Aktien des Unternehmens gehandelt werden: 6. Auf dieser Seite: Kurs und Chart, Dividenden, größte Aktionäre und Entwicklung der Aktienanzahl.

Über das Unternehmen

Website
merck.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Hauptsitz
RAHWAY, Germany
CEO
Dr. Kai Beckmann
Mitarbeiter
62 136
Ausstehende Aktien
646.21 Mio. Stand 2026-07-31
Streubesitz
644.35 Mio.
Marktkapitalisierung
67.93 Mrd. USD
Insider
0%
Institutionelle Anleger
0.02%
Branche (SIC)
Pharmaceutical Preparations
ISIN
US58933Y1055
LEI
4YV9Y5M8S0BRK1RP0397
Beschreibung

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Börsen und Ticker

BörseTickerWährungPreisTyp
US USA StocksMRKUSD141.94 +1.72%Stammaktie
LSE London Stock Exchange0QAHUSD148.65 -0.12%Stammaktie
MI Borsa Italiana (Milan)1MRKXEUR125.02 +0.58%Stammaktie
MX Mexican Stock ExchangeMRKMXN—Stammaktie
VI Vienna Stock ExchangeMRKEUR129.76Stammaktie
XETRA Xetra6MKEUR129.78 +0.09%Stammaktie

Kurs über 3 Monate

Tag mit Kursanstieg Tag mit Kursrückgang Ex-Dividenden-Tag ZahltagTag mit der Maus berühren / antippen — Eröffnungs-, Schluss-, Höchst- und Tiefstkurs

Dividenden

Letzte 12 Monate, LSE:0QAH: 3.4 USD (4 Zahl.)

Merck KGaA ADR (0QAH) zahlt vierteljährlich Dividenden. In den letzten 12 Monaten wurde 3.4 USD pro Aktie gezahlt (Zahlungen: 4). Das entspricht etwa 2.29% des aktuellen Aktienkurses. Basierend auf der Zahlungshistorie wird der nächste Ex-Dividenden-Tag um den 15.12.2026 erwartet.

Ex-TagAuszahlungBetrag%TypTicker
2026-09-15—0.8500 USD0.6/2.3 %vierteljährlichLSE:0QAH
2026-06-15—0.8500 USD0.6/2.8 %vierteljährlichLSE:0QAH
2026-03-16—0.8500 USD0.6/2.8 %vierteljährlichLSE:0QAH
2025-12-15—0.8500 USD0.6/2.8 %vierteljährlichLSE:0QAH
2025-09-15—0.8100 USD0.5/2.7 %vierteljährlichLSE:0QAH
2025-06-16—0.8100 USD0.5/2.7 %vierteljährlichLSE:0QAH
2025-03-17—0.8100 USD0.5/2.1 %vierteljährlichLSE:0QAH
2024-12-16—0.8100 USD0.5/2.1 %vierteljährlichLSE:0QAH
2024-09-16—0.7700 USD0.5/2.1 %vierteljährlichLSE:0QAH
2024-06-17—0.7700 USD0.5/2.0 %vierteljährlichLSE:0QAH
2024-03-14—0.7700 USD0.5/2.0 %vierteljährlichLSE:0QAH
2023-12-14—0.7700 USD0.5/2.0 %vierteljährlichLSE:0QAH
2023-09-14—0.7300 USD0.5/2.0 %vierteljährlichLSE:0QAH
2023-06-14—0.7300 USD0.5/1.9 %vierteljährlichLSE:0QAH
2023-03-14—0.7300 USD0.5/1.9 %vierteljährlichLSE:0QAH
2022-12-14—0.7300 USD0.5/1.9 %vierteljährlichLSE:0QAH
2022-09-14—0.6900 USD0.5/1.9 %vierteljährlichLSE:0QAH
2022-06-14—0.6900 USD0.5/1.4 %vierteljährlichLSE:0QAH
2022-03-14—0.6900 USD0.5/0.9 %vierteljährlichLSE:0QAH
2021-12-14—0.6900 USD0.5/0.5 %vierteljährlichLSE:0QAH

Neuigkeiten diese Woche

Noch keine Nachrichten von der Website des Unternehmens.

Anzeige

Größte Anteilseigner

InhaberAnteilAktienBerichtsdatum
BlackRock9.2%227 Mio.2026-06-30
Vanguard Capital Managem…6.54%161.32 Mio.2026-06-30
State Street Corporation4.88%120.41 Mio.2026-06-30
Wellington Management Gr…3.5%86.25 Mio.2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%78.41 Mio.2026-06-30
Vanguard Portfolio Manag…2.75%67.74 Mio.2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%64 Mio.2026-06-30
Geode Capital Management…2.46%60.74 Mio.2026-06-30
Charles Schwab Investmen…2.2%54.37 Mio.2026-06-30
Morgan Stanley1.97%48.64 Mio.2026-06-30
FMR, LLC1.84%45.44 Mio.2026-06-30
JPMORGAN CHASE & CO1.78%43.89 Mio.2026-06-30
iShares Trust-iShares Co…1.33%32.89 Mio.2026-08-31
Fidelity Concord Street…1.29%31.94 Mio.2026-07-31
SCHWAB STRATEGIC TRUST-S…1.25%30.86 Mio.2026-05-31
SPDR S&P 500 ETF TRUST-S…1.22%30.22 Mio.2026-08-31
VANGUARD INDEX FUNDS-Van…0.95%23.51 Mio.2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%17.75 Mio.2026-08-31
VANGUARD SPECIALIZED FUN…0.65%15.95 Mio.2026-07-31
VANGUARD SPECIALIZED FUN…0.57%13.97 Mio.2026-07-31
DAVIS ROBERT M (Chief Ex…≈0.02%450 3512026-04-29
CHATTOPADHYAY SANAT (Off…≈0.01%200 6752026-04-29
DELUCA RICHARD ROBERT JR…≈0%110 1672026-08-12
LI DEAN Y (Officer)≈0%94 4312026-04-29
LITCHFIELD CAROLINE (Chi…≈0%92 3002026-04-29
ZACHARY JENNIFER L (Gene…≈0%45 5092026-08-12
GUINDO CHIRFI (Officer)≈0%36 6132026-08-13
WILLIAMS DAVID MICHAEL (…≈0%31 7162026-08-05
ROMANELLI JOSEPH EDWARD…≈0%28 7392026-01-26
OOSTHUIZEN JOHANNES JACO…≈0%21 8952026-04-29
Trust for Professional M…0%24 8032026-05-31
Rhumbline Advisers0%10 9192026-06-30
SP Funds Trust-SP Funds…0%6 5422026-07-31
Atlas Capital Advisors I…0%2 4672026-06-30
Gamma Investing LLC0%2 3022026-06-30
Salomon & Ludwin, LLC0%3562026-06-30
PNC Financial Services G…0%22026-06-30
The Vanguard Group———